Literature DB >> 30539519

Down-Regulation of APTR and it's Diagnostic Value in Papillary and Anaplastic Thyroid Cancer.

Ke Zhang1,2, Cuilin Li3, Jianqiu Liu1,2, Zhi Li1,2, Chao Ma4.   

Abstract

APTR has been employed as a potential biomarker attributing to it was involved in carcinogenesis and malignancy's progression. However, the roles of APTR in papillary thyroid cancer (PTC) and anaplastic thyroid cancer (ATC) are unclear. In the present study, we aimed to explore the relative expression of APTR in PTC and ATC tissues and the relation between APTR expression and PTC clinicopathological features. We analyzed APTR expression in PTC and ATC by investigating data obtained from the Gene Expression Omnibus (GEO) database. Then, we tested 76-pair PTC and adjacent normal samples by qRT-PCR, and the result was in accordance with the analysis in GEO datasets. Chi-square (χ2) analysis was employed to evaluate the association between APTR and PTC clinical features. These results showed that APTR was negatively related to TNM stages, distant metastasis. In addition, we further evaluated the feasibility of using APTR to detect PTC and ATC patients by the receiver operating characteristic (ROC) and the area under curve (AUC). These findings implied that down-regulation of APTR is correlated with tumorigenesis, also indicated that the potential diagnostic value of APTR for detecting PTC and ATC patients.

Entities:  

Keywords:  APTR; Anaplastic thyroid cancer (ATC); Diagnosis; Papillary thyroid cancer (PTC); ROC

Mesh:

Substances:

Year:  2018        PMID: 30539519     DOI: 10.1007/s12253-018-0561-y

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  27 in total

1.  Long non-coding RNA APTR promotes the activation of hepatic stellate cells and the progression of liver fibrosis.

Authors:  Fujun Yu; Jianjian Zheng; Yuqing Mao; Peihong Dong; Guojun Li; Zhongqiu Lu; Chuanyong Guo; Zhanju Liu; Xiaoming Fan
Journal:  Biochem Biophys Res Commun       Date:  2015-06-01       Impact factor: 3.575

2.  A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic.

Authors:  G Tomás; M Tarabichi; D Gacquer; A Hébrant; G Dom; J E Dumont; X Keutgen; T J Fahey; C Maenhaut; V Detours
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

3.  New functional activities for the p21 family of CDK inhibitors.

Authors:  J LaBaer; M D Garrett; L F Stevenson; J M Slingerland; C Sandhu; H S Chou; A Fattaey; E Harlow
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

4.  LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway.

Authors:  Xiao-Ming Wang; Yang Liu; Yu-Xia Fan; Zheng Liu; Qing-Ling Yuan; Meng Jia; Zu-Shi Geng; Ling Gu; Xiu-Bo Lu
Journal:  Cancer Biol Ther       Date:  2018-05-03       Impact factor: 4.742

Review 5.  LncRNAs and miRNAs: potential biomarkers and therapeutic targets for prostate cancer.

Authors:  Guoxing Ma; Mingqing Tang; Yaqing Wu; Xiaoming Xu; Feng Pan; Ruian Xu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

6.  LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer.

Authors:  Yuan Qin; Wei Sun; Hao Zhang; Ping Zhang; Zhihong Wang; Wenwu Dong; Liang He; Ting Zhang; Liang Shao; Wenqian Zhang; Changhao Wu
Journal:  Endocrine       Date:  2018-01-11       Impact factor: 3.633

7.  Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.

Authors:  Christina A von Roemeling; Laura A Marlow; Anthony B Pinkerton; Angela Crist; James Miller; Han W Tun; Robert C Smallridge; John A Copland
Journal:  J Clin Endocrinol Metab       Date:  2015-02-12       Impact factor: 5.958

Review 8.  Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.

Authors:  Chandrakanth Are; Ashok R Shaha
Journal:  Ann Surg Oncol       Date:  2006-02-15       Impact factor: 5.344

9.  A new lncRNA, APTR, associates with and represses the CDKN1A/p21 promoter by recruiting polycomb proteins.

Authors:  Masamitsu Negishi; Somsakul P Wongpalee; Sukumar Sarkar; Jonghoon Park; Kyung Yong Lee; Yoshiyuki Shibata; Brian J Reon; Roger Abounader; Yutaka Suzuki; Sumio Sugano; Anindya Dutta
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

10.  REST, not REST4, is a risk factor associated with radiotherapy plus chemotherapy efficacy in glioma.

Authors:  Cuilin Li; Hecun Zou; Zhifei Wang; Xinyue Tang; Xitang Fan; Ke Zhang; Jianqiu Liu; Zhi Li
Journal:  Drug Des Devel Ther       Date:  2018-05-22       Impact factor: 4.162

View more
  1 in total

1.  Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAFV600E Mutation and Clinicopathological Features.

Authors:  Gui-You Li; Hai-Long Tan; Pei Chen; Hui-Yu Hu; Mian Liu; Deng-Jie Ou-Yang; Rooh-Afza Khushbu; Deepak Pun; Jin-Dong Li; Zhi-Peng Zhang; Qiong Yang; Peng Huang; Shi Chang
Journal:  Cancer Manag Res       Date:  2020-05-13       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.